Table 5.
Psychotropic Medication Use in Celiac Disease, PWAGs, and Controls, NHANES 2009–2012
| Psychotropic Medications | Total sample | Controls n (%) |
CD n (%) |
p value* | PWAG n (%) |
p value• |
|---|---|---|---|---|---|---|
| None | 5,213 (72.35) |
5,127 (72.33) |
30 (70.43) |
56 (76.81) |
||
| Any | 1,688 (27.65) |
1,661 (27.67) |
13 (29.57) |
0.82 | 14 (23.19) |
0.60 |
| Antidepressant | 1,091 (19.35) |
1,073 (19.38) |
11 (24.67) |
0.47 | 7 (11.66) |
0.30 |
| Antipsychotic | 189 (2.14) |
186 (2.17) |
0 | NC | 3 (1.57) |
0.61 |
| Anxiolytics, sedatives, and hypnotics | 572 (8.98) |
566 (9.08) |
3 (4.46) |
0.28 | 3 (3.02) |
0.04 |
| Mood stabilizer | 88 (1.49) |
86 (1.44) |
0 | NC | 2 (7.65) |
0.02 |
| Sympathomimetic | 248 (3.47) |
245 (3.49) |
1 (3.92) |
0.90 | 2 (0.87) |
0.04 |
*
CD vs Controls
•
PWAGs vs Controls